Orexo AB (ORX) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.344x

Based on the latest financial reports, Orexo AB (ORX) has a cash flow conversion efficiency ratio of -0.344x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-93.30 Million ≈ $-10.04 Million USD) by net assets (Skr271.30 Million ≈ $29.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ORX stock market capitalisation for the company's overall valuation and market capitalisation.

Orexo AB - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Orexo AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Orexo AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Orexo AB ranked by their cash flow conversion efficiency. Explore Orexo AB (ORX) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
TagMaster AB Series B
ST:TAGM-B
0.129x
British Land Company PLC
LSE:BLND
0.025x
Anson Resources Limited
F:9MY
-0.046x
Full Wang International Development Co Ltd
TWO:6219
-0.136x
Hardwyn India Limited
NSE:HARDWYN
0.012x
OFS Capital Corp
NASDAQ:OFS
0.154x
EQ Inc.
V:EQ
-0.293x
PJ Metal Co. Ltd
KQ:128660
-0.274x

Annual Cash Flow Conversion Efficiency for Orexo AB (2002–2025)

The table below shows the annual cash flow conversion efficiency of Orexo AB from 2002 to 2025. View ORX stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr490.60 Million
≈ $52.80 Million
Skr173.00 Million
≈ $18.62 Million
0.353x +36.20%
2024-12-31 Skr-126.30 Million
≈ $-13.59 Million
Skr-32.70 Million
≈ $-3.52 Million
0.259x +116.05%
2023-12-31 Skr58.90 Million
≈ $6.34 Million
Skr-95.00 Million
≈ $-10.22 Million
-1.613x -99.71%
2022-12-31 Skr193.90 Million
≈ $20.87 Million
Skr-156.60 Million
≈ $-16.85 Million
-0.808x -23.30%
2021-12-31 Skr349.60 Million
≈ $37.62 Million
Skr-229.00 Million
≈ $-24.64 Million
-0.655x -2277.60%
2020-12-31 Skr558.50 Million
≈ $60.10 Million
Skr16.80 Million
≈ $1.81 Million
0.030x -92.60%
2019-12-31 Skr706.40 Million
≈ $76.02 Million
Skr287.00 Million
≈ $30.89 Million
0.406x -20.07%
2018-12-31 Skr476.10 Million
≈ $51.24 Million
Skr242.00 Million
≈ $26.04 Million
0.508x +14.11%
2017-12-31 Skr329.10 Million
≈ $35.42 Million
Skr146.60 Million
≈ $15.78 Million
0.445x -11.51%
2016-12-31 Skr310.30 Million
≈ $33.39 Million
Skr156.20 Million
≈ $16.81 Million
0.503x +231.25%
2015-12-31 Skr266.46 Million
≈ $28.68 Million
Skr-102.19 Million
≈ $-11.00 Million
-0.384x +64.19%
2014-12-31 Skr455.02 Million
≈ $48.97 Million
Skr-487.30 Million
≈ $-52.44 Million
-1.071x +34.30%
2013-12-31 Skr161.46 Million
≈ $17.38 Million
Skr-263.20 Million
≈ $-28.32 Million
-1.630x -1187.18%
2012-12-31 Skr191.19 Million
≈ $20.58 Million
Skr28.67 Million
≈ $3.09 Million
0.150x +139.79%
2011-12-31 Skr311.10 Million
≈ $33.48 Million
Skr-117.23 Million
≈ $-12.62 Million
-0.377x -310.64%
2010-12-31 Skr468.24 Million
≈ $50.39 Million
Skr-42.97 Million
≈ $-4.62 Million
-0.092x +62.41%
2009-12-31 Skr548.66 Million
≈ $59.04 Million
Skr-133.93 Million
≈ $-14.41 Million
-0.244x -37.04%
2008-12-31 Skr569.78 Million
≈ $61.32 Million
Skr-101.49 Million
≈ $-10.92 Million
-0.178x +25.50%
2007-12-31 Skr671.25 Million
≈ $72.24 Million
Skr-160.49 Million
≈ $-17.27 Million
-0.239x -206.76%
2006-12-31 Skr324.35 Million
≈ $34.91 Million
Skr-25.28 Million
≈ $-2.72 Million
-0.078x +41.80%
2005-12-31 Skr338.91 Million
≈ $36.47 Million
Skr-45.38 Million
≈ $-4.88 Million
-0.134x +33.29%
2004-12-31 Skr79.44 Million
≈ $8.55 Million
Skr-15.94 Million
≈ $-1.72 Million
-0.201x +73.90%
2003-12-31 Skr35.88 Million
≈ $3.86 Million
Skr-27.59 Million
≈ $-2.97 Million
-0.769x +5.68%
2002-12-31 Skr25.52 Million
≈ $2.75 Million
Skr-20.80 Million
≈ $-2.24 Million
-0.815x --

About Orexo AB

ST:ORX Sweden Drug Manufacturers - Specialty & Generic
Market Cap
$48.39 Million
Skr449.63 Million SEK
Market Cap Rank
#22110 Global
#410 in Sweden
Share Price
Skr12.80
Change (1 day)
-0.31%
52-Week Range
Skr12.74 - Skr41.60
All Time High
Skr85.70
About

Orexo AB (publ), a pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; Edluar for the treatment of insomnia; and Diabac… Read more